Biotricity is trading 7.6% higher at $0.07 on September 28, 2026, with no identified company-specific catalyst.

  • Its release archive lists February 11, 2026, as its latest press release, with no September 28 announcement shown.
  • Broader markets are down more than 0.5%, so they do not align with the gain.
  • Supplied price context shows sharp swings in recent sessions, but does not establish a cause.